Eiko Lifesciences Ltd — Updates, 29-07-2025: Company Update

Eiko LifeSciences has announced a special window for shareholders to re-lodge physical share transfer requests that were previously rejected or unprocessed. This limited-time opportunity allows investors to address past issues, with all re-lodged shares subsequently being issued only in dematerialized form. Furthermore, the company reminds all physical share holders about the ongoing requirement to furnish their PAN, KYC details, and nominations. This move helps simplify historical share transfer complexities and ensures shareholder data compliance. For any queries, investors can reach out to the company or its RTA.